Los Angeles Award is Third Consecutive Medical Cannabis Cup Accolade
SAN DIEGO, Feb. 10, 2014 (GLOBE NEWSWIRE) — Medical Marijuana Inc. (OTC Pink:MJNA) is pleased to inform shareholders and the general public that HempMedsPX™—a corporate portfolio company of Medical Marijuana, Inc. and the exclusive master distributor and contracted marketing company for CannaVest Corp.—represented CBD Simple by PhytoSPHERE Systems, a CannaVest Corp. brand, at the 2014 High Times Medical Cannabis Cup competition in Los Angeles that garnered the Cannabis Cup award for Highest CBD Concentrate. This world-renowned judging event featured entries by the most prominent growers, breeders and producers of cannabis and cannabis products worldwide. HempMedsPX™ also represented the winner of the 2013 High Times Cannabis Cup competition in Amsterdam, 2013 Seattle High Times Cannabis Cup, and 2013 Michigan Medical Marijuana Conference “Green Cup” contests for Highest (hemp) CBD Concentrate.
A photo accompanying this release is available at http://www.globenewswire.com/newsroom/prs/?pkgid=23501
“We are extremely pleased at the positive feedback from thousands of attendees at the High Times Cannabis Cup in Los Angeles in support of hemp-based CBD products. It is truly an honor to represent the third consecutive Medical Cannabis Cup award winner for Highest CBD Concentrate. This latest accolade further assists HempMedsPX with educating the public about the world’s purest, most concentrated all-natural CBD-rich hemp oil products,” states Michelle Sides – COO of Medical Marijuana, Inc.
CBD Simple is pharmaceutical-grade CBD-rich hemp oil prototype developed by PhytoSPHERE Systems. It is not available to the public for purchase, and is intended for use with future product development. Available now to consumers is Real Scientific Hemp Oil™ (RSHO™), the highest quality, all-natural, super concentrated CBD nutritional supplement on the market today. RSHO™ is the world’s first standardized CBD-rich hemp oil that combines the power of hemp with the science of Mother Nature. All of the CBD-rich hemp oil product lines that HempMedsPX™ represents are derived from the non-GMO industrial hemp plant, and are legal to purchase in all fifty states.
Recognized as the world’s purest CBD-rich hemp oil, RSHO™ is made from sustainably-grown industrial hemp by generational farmers, without pesticides, herbicides, or chemical fertilizers. This CBD-rich hemp oil undergoes multiple lab tests, including independent laboratory analysis, before retail packaging to ensure consistency and quality. Due to unique hemp plant cultivars and scalable cutting-edge production technologies, HempMedsPX™ and PhytoSPHERE are actively meeting the increasing global consumer demand for CBD-rich hemp oil.
CBD-rich hemp oil is also offered through the Cibdex™ line of everyday supplements. Cibdex™ tinctures are available in 100mg and 500mg concentrations, and Cibdex™ vegan capsules deliver 25mg of hemp CBD in each serving. More information on these CBD-rich hemp oil brands can be found at:
The products that HempMedsPX™ represents were recently featured by Fox News, CNBC and top ranked Hispanic news broadcast Univision. These innovative CBD-rich hemp oil products will be seen much more frequently in upcoming documentaries and in mainstream news media. Medical Marijuana Inc.’s Red Dice Holdings LLC’s Dixie Botanicals brand was also recently featured on CNBC.
HempMedsPX™ offers mainstream marketing, sales, customer service, and logistics for the cannabis industry. HempMedsPX™ is a corporate portfolio company of Medical Marijuana, Inc. (OTC Pink:MJNA) and the exclusive master distributor and contracted marketing company for CannaVest Corp. (OTC:CANV) and Medical Marijuana Inc. In addition to handling sales and distribution, HempMedsPX™ is the communication hub for the Medical Marijuana Inc. portfolio of companies.
About Medical Marijuana Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For more information, please visit the company’s website at: www.MedicalMarijuanaInc.com
About CannaVest Corp.
CannaVest Corp. is in the business of investing and developing hemp-based cannabinoid companies. CannaVest Corp. also develops, produces, markets and sells end-consumer products to the nutraceutical industry containing the hemp plant extract, cannabidiol (CBD). Additionally, the company resells—to third parties—raw product acquired by CannaVest Corp. pursuant to the company’s international supply relationships. CannaVest Corp. seeks to take advantage of an emerging worldwide trend to re-energize the production of industrial hemp and to foster its many uses for consumers.Cannabinoids (cannabidiol/CBD) are natural constituents of the hemp plant, and CBD is derived from hemp stalk and seed. Additional information is available from OTCMarkets.com or by visiting CannaVest.com.
About PhytoSPHERE Systems
PhytoSPHERE Systems is a global phytocannabinoid biotechnology company based in San Diego, California with an exclusive license for use by CannaVest Corp. (OTC:CANV). The company utilizes advanced cultivation methods and state-of-the-art processing technology leading to development of pharmaceutical, nutraceutical and food products.
PhytoSPHERE Systems, the manufacturer of the CBD-rich hemp oil used in Real Scientific Hemp Oil (RSHO), has developed special cultivars (similar to “strains”) that produce hemp that is especially rich in CBD, making it possible for PhytoSPHERE to offer all-natural products with high concentrations of hemp-based CBD. For more information, visit: PhytoSPHERESystems.com
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
Medical Marijuana, Inc., CannaVest Corp., and HempMedsPX do not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell and distribute hemp-based products and are involved with Federally Legal Distribution of Medical Marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
The photo is also available at Newscom, www.newscom.com, and via AP PhotoExpress.
For further information, please contact:
Investor relations contact:
Stuart T. Smith